Producing telomerase activators and inhibitors by screening with purified telomerase
US7067283B2 · kind B2 · utility
5Cited by
13References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2004 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Mar 26, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/935
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides purified telomerase and methods of purifying it. The methods involve the use of several sequential steps, including the use of matrices that bind molecules bearing negative charges, matrices that bind molecules bearing positive charges, intermediate-selectivity matrices, methods that separate molecules based on their size, shape, or buoyant density, and by affinity purification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.